4.46
前日終値:
$4.49
開ける:
$4.54
24時間の取引高:
186.19K
Relative Volume:
0.78
時価総額:
$851.94M
収益:
$9.96M
当期純損益:
$-199.33M
株価収益率:
-1.3383
EPS:
-3.3326
ネットキャッシュフロー:
$-93.38M
1週間 パフォーマンス:
+7.99%
1か月 パフォーマンス:
+10.12%
6か月 パフォーマンス:
+31.48%
1年 パフォーマンス:
+79.84%
Inventiva Adr Stock (IVA) Company Profile
IVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
IVA
Inventiva Adr
|
4.46 | 857.67M | 9.96M | -199.33M | -93.38M | -3.3326 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-06 | 開始されました | Wolfe Research | Outperform |
| 2025-09-03 | 再開されました | H.C. Wainwright | Buy |
| 2025-08-27 | 開始されました | Piper Sandler | Overweight |
| 2025-02-21 | 開始されました | TD Cowen | Buy |
| 2024-11-12 | 開始されました | UBS | Neutral |
| 2023-10-27 | 開始されました | Canaccord Genuity | Buy |
| 2023-05-31 | 開始されました | ROTH MKM | Buy |
| 2023-05-19 | アップグレード | Societe Generale | Sell → Buy |
| 2023-03-17 | 開始されました | Stifel | Buy |
| 2022-11-15 | ダウングレード | Societe Generale | Buy → Sell |
| 2021-03-08 | ダウングレード | Societe Generale | Buy → Sell |
| 2020-08-05 | 開始されました | ROTH Capital | Buy |
| 2020-08-04 | 開始されました | Guggenheim | Buy |
| 2020-08-04 | 開始されました | Stifel | Buy |
すべてを表示
Inventiva Adr (IVA) 最新ニュース
The time has not yet come to remove your chips from the table: Inventiva ADR (IVA) - setenews.com
Net margin % of Inventiva SA ADR – LSX:A2P796 - TradingView
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27 novembre 2025 - GlobeNewswire Inc.
Weekly Investment Analysts’ Ratings Changes for Inventiva (IVA) - Defense World
Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why LexinFintech Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Inventiva (NASDAQ:IVA) Price Target Cut to $11.00 by Analysts at Guggenheim - Defense World
ETFs Investing in Inventiva SA ADR Stocks - TradingView
Form 424B5 Inventiva S.A. - StreetInsider
Its Stock Has Paid Off Big Time For Inventiva ADR - Setenews
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Inventiva (NASDAQ:IVA) Upgraded at Wolfe Research - Defense World
Assemblée Générale Mixte du 27 novembre 2025 - GlobeNewswire Inc.
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Up 461.9% in October - MarketBeat
How Does Wall Street Rate Shares Of Inventiva ADR (IVA)? - fostersleader.com
Inventiva (NASDAQ:IVA) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Inventiva (NASDAQ:IVA) Raised to “Hold” at Wall Street Zen - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
FY2025 EPS Estimates for Inventiva Cut by HC Wainwright - MarketBeat
Inventiva (NASDAQ:IVA) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Why You Need Galapagos NV ADR (GLPG) On Your Watchlist - fostersleader.com
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Inventiva Stock Price, Quotes and Forecasts | NASDAQ:IVA - Benzinga
Inventiva (NASDAQ:IVA) Receives “Buy” Rating from Canaccord Genuity Group - Defense World
Inventiva (NASDAQ:IVA) Shares Gap DownTime to Sell? - MarketBeat
Inventiva SA Reports Progress and Challenges in 2025 - TipRanks
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now - sharewise.com
Inventiva (NASDAQ:IVA) Shares Gap UpHere's What Happened - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $14.83 Average Target Price from Analysts - Defense World
Brokerages Set Inventiva S.A. Sponsored ADR (NASDAQ:IVA) PT at $14.83 - MarketBeat
IVA Price History for Inventiva S.A. ADR Stock - Barchart.com
Inventiva (IVA) to Release Quarterly Earnings on Thursday - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Update - MarketBeat
Inventiva (NASDAQ:IVA) Shares Gap Down – Should You Sell? - Defense World
Brokers Set Expectations for Inventiva FY2025 Earnings - MarketBeat
Short Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Increases By 188.0% - MarketBeat
Inventiva (NASDAQ:IVA) Shares Gap Up After Analyst Upgrade - MarketBeat
Inventiva Adr (IVA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):